Risk Of Osteoporosis Drugs

Featured Article

Postmenopausal breast cancer patients who switch from tamoxifen therapy to aromatase inhibitors boost their chances for survival from the disease. Women who make this switch to the newer class of drugs also reduce their risk of endometrial cancer and stroke. But they may also increase their risk of joint pain and osteoporosis.

Read more

More information on "Risk Of Osteoporosis Drugs"

From Our Experts

See more SharePosts »

From Our Sources

More on Osteoporosis »